Search

Search Results
Results 2931 - 2940 of 8241 for Skin Cancer
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Rinvoq intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Caprelsa intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Cotellic intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooke (drospirenone 3 mg and ethinylestradiol 20 micrograms) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooklynn (drospirenone 3 mg and ethinylestradiol 30 micrograms) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brenda-35 ED intended for persons living in Australia.
  • News - 21 Nov 2023
    As an extremely aggressive form of skin cancer, cutaneous melanoma is still associated with a high mortality rate. Enormous progress has recently been made in the fight against deadly metastasis, but...
  • Health - 21 Aug 2023
    Human papilloma virus (HPV) is commonly transmitted between humans through their skin or moist membrane linings such as in the vagina, anus, mouth, or throat. Low risk HPV can result in no easily...
  • News - 10 Aug 2023
    Doctors have been palpating suspicious hardened areas under their patients' skin throughout recorded history.
  • News - 31 Jul 2023
    A new review paper co-authored by two Johns Hopkins pain experts suggests that scrambler therapy, a noninvasive pain treatment, can yield significant relief for approximately 80%–90% of patients with...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.